Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
August 19, 2020
Bjoern Bornkamp, Statistical Methodologist at Novartis and Jose Pinheiro, Senior Director, Johnson & Johnson provided...
Read article
August 13, 2020
Webinar: Adaptive Designs for Dose Finding
Bjoern Bornkamp, Statistical Methodologist at Novartis and Jose Pinheiro, Senior Director, Johnson & Johnson provided...
Read article
July 5, 2016
PROC MCPMod in Bronchodilator Case Study
At a recent PhUSE SDE, Cytel’s Chitra Tirodkar presented how East PROC MCPMod could be used to help solve the problem...
Read article
October 15, 2015
MCPMod: An Introduction
The method for dose-response modeling that is widely called MCPMod allows a sponsor to measure the likelihood that...
Read article
August 10, 2015
Mitigate Phase 3 Clinical Trial Risk by Optimizing Phase 2 Data
When approaching a Phase 3 clinical trial, the need to ‘de-risk’ the massive investment often leads sponsors on a quest...
Read article
July 21, 2015
MCP-Mod for the Modern Dose-Ranging Clinical Trial
MCP-Mod methodology for dose-ranging clinical trials has been gaining popularity since the 2013 publication of the...
Read article